No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Contraindications
-
Hepacivirus / growth & development
-
Hepatitis B virus / growth & development
-
Hepatitis B* / drug therapy
-
Hepatitis B* / prevention & control
-
Hepatitis C* / drug therapy
-
Hepatitis C* / prevention & control
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Virus Activation
Substances
-
Antineoplastic Agents
-
Immunosuppressive Agents